These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17011389)

  • 21. Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms.
    Kuo HC
    Urology; 2007 Aug; 70(2):272-6. PubMed ID: 17826488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of antimuscarinics to alpha-blockers for treatment of lower urinary tract symptoms in men: a meta-analysis.
    Xin Z; Huang Y; Lu J; Zhang Q; Chen C
    Urology; 2013 Aug; 82(2):270-7. PubMed ID: 23896090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and experimental aspects of Adreno-muscarinic synergy in the bladder base and prostate.
    Roosen A; Blake-James BT; Wood D; Fry CH
    Neurourol Urodyn; 2009; 28(8):938-43. PubMed ID: 19618452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α-Blockers and antimuscarinics for male lower urinary tract symptoms: the search goes on.
    Gratzke C; Andersson KE
    Eur Urol; 2013 Jan; 63(1):166-7; discussion 168. PubMed ID: 22959051
    [No Abstract]   [Full Text] [Related]  

  • 25. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
    Liu HT; Kuo HC
    Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
    Kaiho Y; Nishiguchi J; Kwon DD; Chancellor MB; Arai Y; Snyder PB; Yoshimura N
    BJU Int; 2008 Mar; 101(5):615-20. PubMed ID: 18070178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower urinary tract symptoms - current management in older men.
    Arianayagam M; Arianayagam R; Rashid P
    Aust Fam Physician; 2011 Oct; 40(10):758-67. PubMed ID: 22003476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining the role of overactive bladder treatments in men with lower urinary tract symptoms.
    Lemack GE
    Nat Clin Pract Urol; 2007 Apr; 4(4):174-5. PubMed ID: 17415351
    [No Abstract]   [Full Text] [Related]  

  • 29. Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity?
    Serati M; Salvatore S; Uccella S; Cardozo L; Bolis P
    Eur Urol; 2009 Mar; 55(3):713-9. PubMed ID: 18584946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: Where do we stand in 2006?
    Irani J
    Eur Urol; 2006 Oct; 50(4):653-4. PubMed ID: 16899335
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of antimuscarinics in patients with lower urinary tract symptoms for BPH and overactive bladder].
    Ruiz Cerdá JL
    Actas Urol Esp; 2006 Oct; 30(9):849-55. PubMed ID: 17175924
    [No Abstract]   [Full Text] [Related]  

  • 32. Male overactive bladder: pharmacotherapy for the male.
    Giannitsas K; Athanasopoulos A
    Curr Opin Urol; 2013 Nov; 23(6):515-9. PubMed ID: 23851386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
    Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
    BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re: Antimuscarinics and bladder outlet obstruction: from a contraindication to an indication?
    Wein AJ
    J Urol; 2011 Apr; 185(4):1380-1. PubMed ID: 22098973
    [No Abstract]   [Full Text] [Related]  

  • 35. Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity?
    Tanaka Y; Masumori N; Itoh N; Furuya S; Ogura H; Tsukamoto T
    Int J Urol; 2006 Nov; 13(11):1398-404. PubMed ID: 17083391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of lower urinary tract symptoms in men with progressive neurological disease.
    Woderich R; Fowler CJ
    Curr Opin Urol; 2006 Jan; 16(1):30-6. PubMed ID: 16385198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscarinic and purinergic receptor expression in the urothelium of rats with detrusor overactivity induced by bladder outlet obstruction.
    Kim JC; Yoo JS; Park EY; Hong SH; Seo SI; Hwang TK
    BJU Int; 2008 Feb; 101(3):371-5. PubMed ID: 17922866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination drug therapy improves compliance of the neurogenic bladder.
    Cameron AP; Clemens JQ; Latini JM; McGuire EJ
    J Urol; 2009 Sep; 182(3):1062-7. PubMed ID: 19616807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of antimuscarinics in patients with LUTS-BPH and OAB symptoms: clinical expertise and resistance to lose the fear to urinary retention risk].
    Ruiz Cerdá JL
    Actas Urol Esp; 2008; 32(10):957-60. PubMed ID: 19143285
    [No Abstract]   [Full Text] [Related]  

  • 40. [Medical treatment of voiding problems in men].
    Andersen JT; Nordling J; Walter S
    Ugeskr Laeger; 2007 May; 169(20):1892-4. PubMed ID: 17553364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.